公开(公告)号：US20170189401A1

公开(公告)日：2017-07-06

申请号：US15466925

申请日：2017-03-23

Applicant: GlaxoSmithKline Intellectual Property (No.2) Limited

Inventor： Dominique AMANS ,  Stephen John ATKINSON ,  Lee Andrew HARRISON ,  David Jonathan HIRST ,  Robert Peter LAW ,  Matthew LINDON ,  Alexander PRESTON ,  Jonathan Thomas SEAL ,  Christopher Roland WELLAWAY

IPC: A61K31/506

CPC classification number: A61K31/506 ,  A61K31/4375 ,  A61K31/4706 ,  A61K31/4709 ,  A61K31/496 ,  A61K31/497 ,  A61K31/5377 ,  A61K31/5386 ,  C07D215/227 ,  C07D215/44 ,  C07D215/46 ,  C07D215/48 ,  C07D401/04 ,  C07D401/12 ,  C07D401/14 ,  C07D405/04 ,  C07D405/14 ,  C07D409/12 ,  C07D409/14 ,  C07D413/04 ,  C07D413/12 ,  C07D413/14 ,  C07D417/12 ,  C07D417/14 ,  C07D471/04 ,  C07D471/08 ,  C07D487/08 ,  C07D498/04 ,  C07D498/08

Abstract: The present invention relates to novel compounds, pharmaceutical compositions containing such compounds and to their use in therapy.

公开(公告)号：US20160016966A1

公开(公告)日：2016-01-21

申请号：US14770922

申请日：2014-03-12

Applicant: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED

Inventor： Dominique AMANS ,  Paul BAMBOROUGH ,  Michael David BARKER ,  Rino Antonio BIT ,  John Alexander BROWN ,  Matthew CAMPBELL ,  Neil Stuart GARTON ,  Matthew J. LINDON ,  Tracy Jane SHIPLEY ,  Natalie Hope THEODOULOU ,  Christopher Roland WELLAWAY ,  Susan Marie WESTAWAY

IPC: C07D491/048 ,  A61K31/4355 ,  A61K31/4545 ,  A61K31/5377 ,  A61K31/554 ,  A61K31/553 ,  A61K31/541 ,  A61K31/5025 ,  C07D519/00 ,  A61K31/496 ,  A61K31/551

CPC classification number: C07D491/048 ,  A61K31/4355 ,  A61K31/4545 ,  A61K31/496 ,  A61K31/5025 ,  A61K31/5377 ,  A61K31/541 ,  A61K31/551 ,  A61K31/553 ,  A61K31/554 ,  C07D519/00

Abstract: The present invention relates to novel compounds, pharmaceutical compositions containing such compounds and to their use in therapy.

Abstract translation: 本发明涉及新化合物，含有这些化合物的药物组合物及其在治疗中的用途。

公开(公告)号：US20180303831A1

公开(公告)日：2018-10-25

申请号：US16016955

申请日：2018-06-25

Applicant: GlaxoSmithKline Intellectual Property (No.2) Limited

Inventor： Dominique AMANS ,  Stephen John ATKINSON ,  Lee Andrew HARRISON ,  David Jonathan HIRST ,  Robert Peter LAW ,  Matthew LINDON ,  Alexander PRESTON ,  Jonathan Thomas SEAL ,  Christopher Roland WELLAWAY

IPC: A61K31/506 ,  A61K31/497 ,  C07D401/14 ,  A61K31/4709 ,  A61K31/496 ,  C07D498/08 ,  A61K31/5377 ,  A61K31/5386 ,  A61K31/4375 ,  C07D498/04 ,  C07D487/08 ,  C07D471/08 ,  C07D471/04 ,  C07D417/14 ,  C07D417/12 ,  C07D413/12 ,  C07D413/04 ,  C07D409/14 ,  C07D409/12 ,  C07D405/04 ,  C07D401/12 ,  C07D401/04 ,  C07D215/48 ,  C07D215/46 ,  C07D215/44 ,  C07D215/227 ,  C07D413/14 ,  C07D405/14 ,  A61K31/4706

Abstract: The present invention relates to novel compounds, pharmaceutical compositions containing such compounds and to their use in therapy.